Clicking a link below will scroll the
page down to the relevant section
- A Phase II Study of Docetaxel, Cisplatin, and Fluorouracil with Bevacizumab in Patients with Unresectable or Metastatic Gastroesophageal Adenocarcinoma
Jhawer, Minaxi, MD
[Protocol 06-096]
- A Phase II Study of Epirubicin, Cisplatin, Fluorouracil-Cetuximab, Irinotecan, Cisplatin-Cetuximab, or Folinic acid, Fluorouracil, Oxaliplatin-Cetuximab in Patients with Metastatic Esophageal and Gastroesophageal Junction Cancers
Jhawer, Minaxi, MD
[Protocol 07-145]
- A Phase II Trial of Cetuximab plus Cisplatin and Irinotecan in Patients with Irinotecan- and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer
Ilson, David, MD
[Protocol 06-095]
- A Phase II Trial of Irinotecan, Cisplatin, Bevacizumab, and Concurrent Radiotherapy in Locally Advanced Esophageal Adenocarcinoma
Ilson, David, MD
[Protocol 06-013]
- Quality of Life Outcomes Following Treatment for Esophageal Cancer
Bains, Manjit, MD
[Protocol 03-083]
- A Phase II Study of Docetaxel, Cisplatin, and Fluorouracil with Bevacizumab in Patients with Unresectable or Metastatic Gastroesophageal Adenocarcinoma
Jhawer, Minaxi, MD
[Protocol 06-096]
- A Phase II Study of XL880 in Patients with Poorly Differentiated Metastatic Gastric Cancer
Jhawer, Minaxi, MD
[Protocol 07-138]
- A Phase II Trial of Cetuximab plus Cisplatin and Irinotecan in Patients with Irinotecan- and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer
Ilson, David, MD
[Protocol 06-095]
- A Phase III Trial of Adjuvant Chemoradiation after Surgery for Gastric or Gastroesophageal Cancer
Shah, Manish, MD
[Protocol 06-055]
- A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
Shah, Manish, MD
[Protocol 06-103]
- Early Onset and Familial Gastric Cancer Registry
Shah, Manish, MD
[Protocol 05-118]
- Quality of Life Among Long-term Survivors of Resected Gastric Cancer
Coit, Daniel, MD
[Protocol 04-112]
- A Phase I Study of Flavopiridol in Combination with Radiation in Locally Advanced, Non-Operable Pancreatic Cancer
Schwartz, Gary, MD
[Protocol 02-057]
- A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients with Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma
O'Reilly, Eileen, MD
[Protocol 07-113]
- Clinical Outcomes in Hereditary Cancer
Robson, Mark, MD
[Protocol 06-004]
- Depression, Cytokines, and Pancreatic Cancer
Breitbart, William, MD
[Protocol 05-117]
- Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
Kurtz, Robert, MD
[Protocol 02-102]
|
